These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23837919)

  • 1. The metabolic cost of lowering blood pressure with hydrochlorothiazide.
    Price AL; Lingvay I; Szczepaniak EW; Wiebel J; Victor RG; Szczepaniak LS
    Diabetol Metab Syndr; 2013 Jul; 5(1):35. PubMed ID: 23837919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of angiotensin receptor blockade in combination with hydrochlorothiazide 25 mg in 2121 patients with stage 1-2 hypertension.
    White WB; Davidai G; Schumacher H
    J Hum Hypertens; 2009 Dec; 23(12):817-25. PubMed ID: 19357698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valsartan/hydrochlorothiazide.
    Langtry HD; McClellan KJ
    Drugs; 1999 May; 57(5):751-5; discussion 756-8. PubMed ID: 10353300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative vascular and renal tubular effects of angiotensin II receptor blockers combined with a thiazide diuretic in humans.
    Coltamai L; Maillard M; Simon A; Vogt B; Burnier M
    J Hypertens; 2010 Mar; 28(3):520-6. PubMed ID: 20104189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system.
    Scheen AJ
    Drugs; 2004; 64(22):2537-65. PubMed ID: 15516153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of force-titrated valsartan/hydrochlorothiazide versus amlodipine/hydrochlorothiazide on ambulatory blood pressure in patients with stage 2 hypertension: the EVALUATE study.
    Lacourcière Y; Wright JT; Samuel R; Zappe D; Purkayastha D; Black HR;
    Blood Press Monit; 2009 Jun; 14(3):112-20. PubMed ID: 19384192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telmisartan/hydrochlorothiazide versus valsartan/hydrochlorothiazide in obese hypertensive patients with type 2 diabetes: the SMOOTH study.
    Sharma AM; Davidson J; Koval S; Lacourcière Y
    Cardiovasc Diabetol; 2007 Oct; 6():28. PubMed ID: 17910747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valsartan and hydrochlorothiazide in patients with essential hypertension. A multiple dose, double-blind, placebo controlled trial comparing combination therapy with monotherapy.
    Benz JR; Black HR; Graff A; Reed A; Fitzsimmons S; Shi Y
    J Hum Hypertens; 1998 Dec; 12(12):861-6. PubMed ID: 9883710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive effects of valsartan/hydrochlorothiazide combination in essential hypertension.
    Schmidt A; Adam SA; Kolloch R; Weidinger G; Handrock R
    Blood Press; 2001; 10(4):230-7. PubMed ID: 11800062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of baseline blood pressure in guiding treatment choice: a secondary analysis of the use of valsartan/hydrochlorothiazide as initial therapy in hypertensive adults in a randomized, double-blind, placebo-controlled trial.
    Pool JL; Glazer R; Crikelair N; Levy D
    Clin Drug Investig; 2009; 29(12):791-802. PubMed ID: 19888785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amlodipine/valsartan/hydrochlorothiazide: fixed-dose combination in hypertension.
    Deeks ED
    Am J Cardiovasc Drugs; 2009; 9(6):411-8. PubMed ID: 19929039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A home blood pressure monitoring study comparing the antihypertensive efficacy of two angiotensin II receptor antagonist fixed combinations.
    Bobrie G; Delonca J; Moulin C; Giacomino A; Postel-Vinay N; Asmar R;
    Am J Hypertens; 2005 Nov; 18(11):1482-8. PubMed ID: 16280286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized study to compare valsartan +/- HCTZ versus amlodipine +/- HCTZ strategies to maximize blood pressure control.
    Zappe D; Papst CC; Ferber P;
    Vasc Health Risk Manag; 2009; 5():883-92. PubMed ID: 19898644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valsartan: more than a decade of experience.
    Black HR; Bailey J; Zappe D; Samuel R
    Drugs; 2009; 69(17):2393-414. PubMed ID: 19911855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AT1-receptor blockade improves augmentation index: a double-blind, randomized, controlled study.
    Klingbeil AU; John S; Schneider MP; Jacobi J; Weidinger G; Schmieder RE
    J Hypertens; 2002 Dec; 20(12):2423-8. PubMed ID: 12473867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrochlorothiazide is not the most useful nor versatile thiazide diuretic.
    Vongpatanasin W
    Curr Opin Cardiol; 2015 Jul; 30(4):361-5. PubMed ID: 26049382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy with valsartan/hydrochlorothiazide at doses up to 320/25 mg improves blood pressure levels in patients with hypertension inadequately controlled by valsartan 320 mg monotherapy.
    Tuomilehto J; Tykarski A; Baumgart P; Reimund B; Le Breton S; Ferber P
    Blood Press Suppl; 2008 Jun; 1():15-23. PubMed ID: 18705531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple combination therapy with amlodipine, valsartan, and hydrochlorothiazide vs dual combination therapy with amlodipine and hydrochlorothiazide for stage 2 hypertensive patients.
    Destro M; Crikelair N; Yen J; Glazer R
    Vasc Health Risk Manag; 2010 Sep; 6():821-7. PubMed ID: 20859551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.